Olio

Olio is a US-based company that provides a comprehensive care coordination platform aimed at enhancing patient outcomes through effective communication and collaboration among healthcare stakeholders. Founded in 2017 in Indianapolis, US, Olio specializes in care coordination solutions. The company was established by Aashna Singh, Don Sabani, Sneha Saksena, and Wade Sanders. Currently led by CEO Ben Forrest and Tony Boueri, Olio has engaged in 4 deals, with its most recent funding round being a Series B in April 2025, raising USD 6.

000 mn led by Fulcrum Equity Partners and including Mutual Capital Partners. The total amount raised by the company stands at USD 6. 000 mn with a current valuation of USD 54. 459 mn.

Olio provides a comprehensive care coordination platform designed to improve patient outcomes by connecting all stakeholders involved in healthcare delivery. The platform facilitates real-time communication and case management, enabling seamless collaboration among payers, health systems, primary care providers, and skilled nursing facilities. Key functionalities include organizing appropriate stakeholders around complex levels of care, modernizing referral processes, and elevating care management practices to enhance patient experiences and reduce readmission rates. The company serves a diverse client base across various geographical markets, including the Southwest region of the United States, providing tailored solutions for post-acute providers, behavioral health providers, and payers.

Through its innovative technology, Olio aims to streamline care coordination and improve management efficiencies for healthcare providers, ensuring a focus on quality patient care. Olio's revenue model is based on partnerships and subscriptions with healthcare organizations, including health plans and skilled nursing facilities. Clients engage with Olio through a subscription-based framework, where they access the platform's comprehensive features to manage patient cases effectively. The pricing structure is designed to accommodate various organizational needs and scales, allowing for flexible integration within existing healthcare systems.

The primary revenue streams derive from the utilization of the care coordination platform, which includes client management tools, data analytics, and support services tailored to enhance operational efficiencies. This structured approach to revenue generation underscores Olio’s commitment to delivering value to its partners while fostering improved care coordination outcomes across the healthcare landscape. In April 2025, Olio raised USD 6. 000 mn in Series B funding, led by returning investor Fulcrum Equity Partners with participation from Mutual Capital Partners and other investors.

The company plans to utilize this funding to support product innovations and expand its influence within the global healthcare industry. Future growth strategies include the launch of new product features designed to enhance care coordination and plans for geographic expansion into new markets, though specific regions have not been disclosed.